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University of MichiganThe integrity of tissues is maintained by
adult stem cells during adulthood. How-
ever, recent work indicates that tissues
often contain more than one population
of stem cells that are located at distinct
niches and display different behaviors,
making the role of stem cells in tissue ho-
meostasis far more complex than previ-
ously thought. Generally, each population
of stem cells predominantly contributes to
its compartment in steady-state condi-
tions and tends to display its multipotency
upon damage repair. Interestingly, this
heterogeneity might also underlie the
different types of tumors that can arise in
given tissue. Because the discovery of
stem cell heterogeneity is rather recent, I
am interested in exploring its significance
in health and disease. For instance, which
epigenetic factors determine when and
how different stem cell populations are
established? What mechanisms prevent
their intermingling in healthy tissues but
allow for their multipotency during repair?
Importantly, the tissue-specific disrup-
tion of epigenetic factors often results in
tissue aging and carcinogenesis, and
several chromatin-remodeling factors are
mutated in human cancers. Does the
perturbation of epigenetic factors occur
independently of other agingmechanisms,
or do they converge? How do deregulated
epigenetic factors cooperate with onco-
genes and tumor suppressors to promote
tumorigenesis? I believe that the field of
epigenetics will offer great insights toward
these unknowns in the future.706 Cell Stem Cell 14, June 5, 2014 ª2014 EChromatin Regulator RelocationsRecent genome-wide approaches to map
histone posttranslational modifications
(PTMs) and chromatin regulators (CRs)
during differentiation and reprogramming
have revealed dynamic changes in epige-
netic landscapes with striking clarity.
However, these descriptive approaches
have failed to provide many new mecha-
nistic insights into how CRs are localized,
or displaced, so precisely during these
transitions.
CRs are not drivers of differentiation or
reprogramming. Instead, cell fate deci-
sions are driven by master transcription
factors. What we don’t know from ge-
nome-wide mapping studies is how CRs
follow the instruction of master transcrip-
tion factors. CRs such as the BAF and
Polycomb families formmultiprotein com-
plexes containing numerous protein do-
mains. These domains function to interact
with cofactors, histone PTMs, noncoding
RNAs, and DNA without any apparent
sequence specificity. I am interested in
exploring how these domains combine
to stabilize the precise relocalization of
CRs during cell fate transitions.
It’s exciting to think how new, efficient
DNA editing approaches such as CRISPR
will allow a surgical dissection of the role
of the many domains within protein com-
ponents of CR complexes, as well as the
putative DNA sequences required for their
relocalization. These approaches promise
to shed new light on how CRs relocate to
different target genes during cell fate
changes, which will provide a more com-
plete understanding of differentiation and
reprogramming.lsevier Inc.Obligatory Role of Histone MarksThe past decade or so has witnessed an
explosion of information depicting the
epigenetic landscape of stem cells by
concerted efforts from the chromatin field.
High-resolution genome-wide studies
reveal a ‘‘hyperactive’’ chromatin state in
stem cells with different sets of histone
modifications demarcating distinct regu-
latory elements such as ‘‘poised’’ en-
hancers and promoters. These studies
also show dynamic, reciprocal changes
in histone modifications upon cell fate
alteration, illustrating an intriguing correla-
tion between histone marks and stem cell
functions. In the next decade, we need to
establish whether histone modifications
serve an obligatory role, as opposed to a
‘‘correlative’’ one, in stemcell self-renewal
and differentiation. The advent of pharma-
cological inhibitors against specific his-
tone-modifying enzymes allows the
assessment of dynamic requirements of
histone modifications in these processes,
distinguished from genetic studies that al-
ways lead to concurrent alterations of pro-
tein interaction network. The results
should enlighten us aboutwhether the his-
tone modifications underlie ‘‘epigenetic
memory’’ per se and/or whether they
play a role in setting up the initial ground
rules on which downstream effector pro-
teins act. It will also be important to
examine whether histone modifications
shape the cellular architecture in a way
that efficiently engages reprogramming
factors or lineage-specific transcription
factors and, thus, function as a determin-
istic factor in these processes.
Cell Stem Cell
VoicesChapter 2: Epigenome EditingHaruhiko Koseki
RIKEN Center for Integrative Medical Sciences
Danwei Huangfu
Sloan-Kettering Institute
Natalia Ivanova
Yale UniversityUnderstanding how different cells inter-
pret the same DNA sequence in different
ways is central to biomedical research.
Epigenetics may help us understand why
a muscle cell looks and acts differently
from a liver cell, and ultimately this under-
standing may lead to the generation of
specific cell types of therapeutic interest.
In recent years there has been growing in-
terest in epigenetics, and tremendous
progress has been made. We now have
ways to describe the epigenome with
ever-increasing precision, and new tech-
nologies are being developed to charac-
terize the epigenome at single-base and
single-cell resolution. However, it remains
challenging to make causal links between
changes in the epigenome with the
cellular or organismal phenotypes. To
address causality, current methods typi-
cally use nonspecific approaches, such
as blocking an epigenetic modifier
through genetic or pharmacological ma-
nipulations. Further development of the
field will benefit from introducing epige-
netic changes to specific genomic loci
coupled with precise spatial and temporal
control. Genetic studies are already
benefiting from new tools such as pro-
grammable site-specific nucleases (e.g.,
CRISPR/Cas) for locus-specific gene ed-
iting and optogenetic tools for temporal
and spatial manipulation. It is likely that
in the next 10 years we will see the devel-
opment of a series of analogous or
perhaps better tools to precisely edit the
epigenome, which will enable us to
comprehensively decipher its functional
relevance.Going Beyond Self-RenewalThe ability of embryonic stem cells (ESCs)
to self-renew and give rise to a full reper-
toire of differentiated lineages has capti-
vated biologists for decades. While the
regulatory network that lies beneath self-
renewal is becoming increasingly defined,
the molecular circuitry that defines devel-
opmental potency of the cells remains
largely unknown.
Genome-scale mapping in ESCs and
differentiated cells suggests that chro-
matin holds the key to understanding the
pluripotent state. ESCs maintain low
levels of DNA methylation, and gains in
DNA methylation that occur during differ-
entiation result in lineage-specific gene
silencing. Furthermore, regulatory ele-
ments of developmental genes are
marked by both activating and silencing
histone marks, indicating that epigenetic
priming may be required for differentia-
tion. Although the enzymatic complexes
that regulate DNAmethylation andmodifi-
cation of histones have been identified,
how these complexes are recruited to
specific target sites in ESCs is unclear.
Do the core pluripotency factors guide
the placement of epigenetic marks?
When and how is the epigenetic land-
scape of the pluripotent state assembled
and subsequently taken apart during dif-
ferentiation?
The field needs the tools for analysis
and visualization of chromatin at a sin-
gle-cell level in culture and in developing
embryos to answer these questions.
With the knowledge obtained we should
be able to safely and efficiently guide
pluripotent cells toward specific cell fates
for use in medicine and research.Cell Stem CeMetabolomics in Stem Cell AgingAging modifies tissue stem cell function,
but the underlying mechanisms are
largely unknown. Tissue stem cells are
often kept in a mitotically dormant state,
likely to avoid activation of cellular senes-
cence mechanisms by signals from the
niche and to protect against other envi-
ronmental insults. Despite such protec-
tion, tissue stem cells can sense environ-
mental stimuli and may alter their
properties to maintain tissue homeosta-
sis. I am interested in the potential im-
pacts of metabolites on epigenetic path-
ways in stem cells because they may
provide a link between the environment
and cellular senescence.
One of the main sources of environ-
mental stimuli directed to tissue stem
cells may be metabolites that come from
foods, commensal microbiota, and
various somatic cells. Such metabolites
may affect stem cell function by acting
as substrates for metabolic pathways, co-
enzymes for various regulatory mecha-
nisms, including epigenetic regulatory
systems, and ligands for transcription fac-
tors. Epigenetic regulators such as Poly-
comb are known to suppress cellular
senescence by robustly repressing crit-
ical targets. Epigenetic pathways may
also form an interface to buffer against
metabolic insults on cellular senescence
mechanisms. To validate this model, we
will need to overcome structural complex-
ities of metabolites and functional com-
plexities in epigenetic regulation. System-
atic studies approaching this problem
from both angles and mathematical ap-
proaches to unify these fields may be
necessary.ll 14, June 5, 2014 ª2014 Elsevier Inc. 707
Cell Stem Cell
VoicesEpigenetic VariabilityEran Meshorer
The Hebrew University of Jerusalem
Louise Laurent
University of California, San Diego
Daniel A. Lim
University of California, San FranciscoRecent studies have discovered signifi-
cant epigenetic variability among pluripo-
tent stem cell lines, including abnormal-
ities in imprinting and X chromosome
inactivation. Aberrant epigenetic regula-
tion is associated with many diseases,
including cancer, and thus evidence of
epigenetic instability in pluripotent stem
cells has raised concerns regarding their
potential use in cell transplantation ther-
apy. Certain epigenetic patterns have
been associated with specific derivation
methods or phenotypic characteristics,
including differentiation potential. These
results suggest that epigenetic profiling
may be a way to assess the quality of a
pluripotent stem cell line, in terms of its
safety for clinical applications and its util-
ity as an in vitro model for development
and disease.
In order for this to be accomplished,
several critical areas must be further
explored. The mechanistic pathways
between epigenetic patterns and cellular
phenotype, regulatory interactions
among different epigenetic mechanisms,
and mechanisms for targeting of epige-
netic marks to specific regions of the
genome are largely unknown. Perhaps
most importantly, we do not yet know
how closely the epigenetic marks in
pluripotent stem cells and their deriva-
tives reflect those of their cellular counter-
parts in vivo. I believe that for pluripotent
stem cells to reach their full potential as
clinical therapeutics, it is critical for us to
continue to investigate basic questions
in stem cell biology and epigenetics.708 Cell Stem Cell 14, June 5, 2014 ª2014 ElncRNAs and Brain EpigeneticsThe mammalian genome transcribes
many thousands of unique long noncod-
ing RNAs (lncRNAs). Some lncRNAs
such as Xist have long been known for
their role in epigenetics, and more recent
studies have revealed additional lncRNAs
that interact functionally with chromatin-
modifying factors or other epigenetic reg-
ulators. lncRNA expression is highly tis-
sue specific. In particular, the expansive
set of unique lncRNAs in the brain is
even more specific to different brain re-
gions thanmRNAs andmay also be highly
cell-type specific. This exquisite speci-
ficity of lncRNAs could be useful for cata-
loguing the diverse classes of neural cell
types, as well as for the molecular diag-
nosis of neurological diseases.
Emerging evidence also indicates that
lncRNAs play key roles in the epigenetics
of neural stem cells and brain develop-
ment. We have obtained only glimpses
of the various molecular mechanisms of
lncRNAs, and many more novel functions
will likely soon be discovered. While
epigenetic mechanisms are undoubtedly
critical during brain development, it is
also clear that some of the molecular
mechanisms that underlie the epigenetics
of development are also important in
postmitotic neurons. For instance, active
DNA methylation appears to play a role
in memory formation. Given the emerging
roles of lncRNAs in neurodevelopmental
epigenetics, it will be exciting to learn
whether lncRNAs also play key roles in
learning, memory, and diseases such as
neurodegeneration.lsevier Inc.Epigenetics One Stem at a TimeThese are exciting times for the field of
stem cell epigenetics. Enhanced abilities
to program stem cells and reprogram so-
matic cells combined with the develop-
ment of ‘‘beyond the primary sequence’’
methods that feed the sequencing
monster are driving this field forward at
an increasingly rapid pace. Multilevel
maps of chromatin hypersensitivity, DNA
methylation, chromatin factors, histone
modifications, insulators, chromatin
folding, and more are now routinely being
generated toward a holistic view of the
stem cell epigenome. But while epige-
nomic maps are insightful, they normally
provide correlations, not function. Even
at the most fundamental level, we cannot
always say for certain if, say, an active
chromatin mark is the cause, not the
effect, of transcription. Advances in
genome editing technologies should
enable us to take a step back and test
many of the predictions generated over
the years. A drawback of current whole-
genome methods is that they only reveal
population averages, so existing epige-
nomic profiles fail to explain cell-to-cell
variation. Why do some cells differentiate
or reprogram better than others? Why do
some cells become ectoderm while their
neighbors become endoderm under
similar conditions? The next challenge
will be to take the epigenetic field one
step further by relating chromatin plas-
ticity to function at a single-cell,
genome-wide level. Once this feat is
achieved, the holy grail of programming
cells a la carte will become ever more
feasible.
Cell Stem Cell
Voices3D Genome OrganizationAna Pombo
Berlin Institute for Medical Systems Biology
Maike Sander
University of California, San Diego
Guo-Liang Xu
Shanghai Institute of Biochemistry and CellThe control of gene expression pathways
in the context of tissues and whole organ-
isms is increasingly understood as a com-
plex process, with the role of chromatin
folding and nuclear positioning emerging
as key factors in gene expression out-
comes. Genome sequencing projects
had shown that the colinear distribution
of genes along the DNA fiber matters for
their expression. More recently, micro-
scopy and chromatin conformation cap-
ture have shown that the same may be
true in 3D space. However, we are still
far from grasping what mechanisms un-
derlie the spatial interdependence of
gene expression states, how long-range
chromatin proximity is established within
the 3D nuclear environment, and which
mechanisms sense preferred positioning.
The picture emerging is one in which local
biochemical environments are created
within the nuclear landscape by various
mechanisms, thereby promoting more
effective, robust, or specialized nuclear
functions.
A major goal in understanding tran-
scriptional states globally is to identify
not only active states of transcription but
also the mechanisms that recruit the tran-
scription machinery to silent genes to
prime them for expression in response
to differentiation or extracellular stimuli.
A global and integrated understanding
of the interplay between long-range
chromatin contacts, chromatin states of
protein and/or RNA occupancy andmodi-
fication, and transcriptional and expres-
sion outcomes will be key to unlocking
this puzzle.The Epigenome in DiseaseThe advent of genome-wide DNA
sequencing technology has led to a dra-
matic increase in our knowledge of how
molecular modifications to DNA and chro-
matin affect gene expression. Over the
last 10 years, we have also identified
many of the writers, readers, and erasers
that modify the ‘‘epigenetic code.’’
Furthermore, we have learned that the ep-
igenome is highly dynamic and undergoes
significant change in response to environ-
mental cues and during the aging pro-
cess.
Now, one of the next frontiers is to
explore how the cellular environment
shapes the epigenome and thereby influ-
ences cellular phenotypes. Such knowl-
edge will likely yield an understanding
of the mechanisms underlying common
diseases influenced by both environ-
mental and genetic factors, such as dia-
betes and neurodegenerative diseases.
Genome-wide approaches could help
define genomic loci that are susceptible
to environmental insults, and pluripotent
stem cells (PSCs) could provide a model
for studying environment-epigenome in-
teractions in a human context. PSC-
based approaches should also help
shed light on how genetic variation influ-
ences susceptibility to environmental
stress and predisposes to disease. To
enable such studies, we will need to
develop improved cell models so that
mature disease-relevant cell types can
be studied in meaningful ways ex vivo.
Exploring the role of the epigenome in dis-
ease could reveal epigenetic targets as
highly selective entry points for disease
intervention and could thus lead to new
therapies.Cell Stem CeModel Organisms for EpigeneticsThe study of cell lineage commitment and
conversion will continue to be at the cut-
ting edge. However, the epigenetic mech-
anisms underlying this process are hard
to study in mammals, because obtaining
sufficient individual cells locked into a
given cellular state can be challenging.
The problem is compounded by the fact
that commonly used model organisms
lack some key epigenetic components.
Notably, yeast, worms, and flies all lack
DNA methylation, which is vitally impor-
tant in mammals.
Therefore, there is a need to expand our
tool box. Fortunately, numerous candi-
dates across evolution are available.
Take the single-celled eukaryote Naegle-
ria gruberi as an example. Introduced by
Chandler Fulton in the 1960s to study cell
differentiation, this free-living organism is
famous for its stunning ability to transform
from a crawling, bacteria-eating amoeba
into a fast-swimming flagellate within
1.5 hr. The amoeba’s short doubling time
(every 1.6 hr) adds another advantage.
The promise of using protozoa is
showcased by the recent discovery of
the Tet-mediated oxidative demethylation
pathway, based on the homology of
mammalian Tet proteins to thymidine hy-
droxylases of trypanosomes. Naegleria
has the Tet pathway; what role does it
play? With new molecular techniques,
barriers to using nonstandard models
have started to dissipate. Such models
can be expected to reveal new and poten-
tially generalizable aspects of epigenetic
regulation and can thus be anticipated to
contribute to future cell reprogramming
research.
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